Dr. Hall also has a Masters in documentary film. Dr. Hall’s recent research has focused on catechol-O-methyltransferase (COMT), an enzyme that metabolizes catecholamines such as dopamine and epinephrine and that has pleiotropic effects in a broad set of diseases and treatments. Among her recent accomplishments is a landmark paper published in PLOS ONE describing COMT as a genetic marker of placebo response, and a broader review in Trends in Molecular Medicine on the impact of genetics on the placebo response. Her work has led to the coining of the term “placebome”, which was added to Jargonwatch by WIRED magazine in 2015. Her research has been the focus of numerous articles including features in Science, The Atlantic, The Economist and Discover magazines.